Market Cap

BioTech Medics, Inc. Market Capitalization:

$6.9 Million

USD as of Jan. 1, 2024

business BioTech Medics, Inc. Company Profile

BioTech Medics, Inc. Main Stock Listing

OTC: BMCS

Market Capitalization History of BioTech Medics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BioTech Medics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $6.9 M 373.82%
Jan. 1, 2023 $1.4 M -84.53%
Jan. 1, 2022 $9.4 M 215.70%
Jan. 1, 2021 $3.0 M 196.55%
Jan. 1, 2020 $999,664 163.64%
Jan. 1, 2019 $379,183 -42.11%
Jan. 1, 2018 $654,952 245.46%
Jan. 1, 2017 $189,591 83.33%
Jan. 1, 2016 $103,413 -64.71%
Jan. 1, 2015 $293,005 21.43%
Jan. 1, 2014 $241,298 -86.67%
Jan. 1, 2013 $1.8 M -12.50%
Jan. 1, 2012 $2.1 M -14.29%
Jan. 1, 2011 $2.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BioTech Medics, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

BioTech Medics, Inc. has the following listings and related stock indices.


Stock: OTC: BMCS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.